Dr Christine Bestvina discusses EGFR treatment shifts, KRAS trial data, and expanding clinical trial access for community oncologists. Lung cancer treatment has undergone a remarkable transformation ...

LAGOS – Shell Nigeria Exploration and Production Company Limited (SNEPCo) and the Nigerian National Petroleum Company Limited (NNPC) have donated an Endobronchial Ultrasound (EBUS) system and a Body ...

Isolated antineutrophil cytoplasmic antibody-associated interstitial lung disease is an increasingly recognized fibrotic ILD phenotype.

University of Colorado Denver Biomedical Engineering Associate Professor Chelsea Magin is developing a lung model to help ...

Deupirfenidone slowed the progression of lung disease over 26 weeks in patients with idiopathic pulmonary fibrosis in a clinical trial.

In the 2000s, when the AIDS pandemic hit South Africa, we were seeing a lot of children dying from HIV. That was just before ...

NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...

Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...

The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.

Patients with Medicare Part D insurance plans experience uneven and “restrictive” coverage of certain drugs and drug classes ...

Why is kidney disease research so important? In China, more than 10% of adults suffer from chronic kidney disease (CKD), while in the United States the incidence rate is as high as 14%. There are more ...

Background Sex-based differences in immune response are well established, but whether men and women derive comparable benefit ...